| 1 |
32623597 | Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats. | 2021 Dec |
2 |
| 2 |
32713353 | Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats. | 2021 Feb 28 |
1 |
| 3 |
34627773 | Coadministration of sitagliptin or metformin has no major impact on the adverse metabolic outcomes induced by dexamethasone treatment in rats. | 2021 Dec 1 |
1 |
| 4 |
34884960 | Modulation of Prostanoids Profile and Counter-Regulation of SDF-1α/CXCR4 and VIP/VPAC2 Expression by Sitagliptin in Non-Diabetic Rat Model of Hepatic Ischemia-Reperfusion Injury. | 2021 Dec 5 |
1 |
| 5 |
32544878 | GABA requires GLP-1R to exert its pancreatic function during STZ challenge. | 2020 Sep |
1 |
| 6 |
32653415 | Suppression of BACE1 and amyloidogenic/RAGE axis by sitagliptin ameliorates PTZ kindling-induced cognitive deficits in rats. | 2020 Sep 1 |
3 |
| 7 |
31030714 | [Sitagliptin inhibits cell apoptosis and inflammation of renal tissues in diabetic nephropathy model rats]. | 2019 Mar |
1 |
| 8 |
31398418 | The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes. | 2019 Oct 1 |
1 |
| 9 |
29325553 | Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking. | 2018 Jan 11 |
5 |
| 10 |
30086287 | Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures. | 2018 Oct |
3 |
| 11 |
30195035 | Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner. | 2018 Oct 15 |
1 |
| 12 |
27922176 | Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction. | 2017 Nov |
2 |
| 13 |
28329747 | Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy. | 2017 |
1 |
| 14 |
28423178 | Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury. | 2017 Jul |
1 |
| 15 |
28433470 | Daily supplementation of dietary protein improves the metabolic effects of GLP-1-based pharmacotherapy in lean and obese rats. | 2017 Aug 1 |
2 |
| 16 |
29254185 | Hepatoprotective potential of isoquercitrin against type 2 diabetes-induced hepatic injury in rats. | 2017 Nov 24 |
1 |
| 17 |
27122056 | Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase. | 2016 Jun |
1 |
| 18 |
25837922 | Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats. | 2015 Mar |
2 |
| 19 |
24817793 | Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals. | 2014 |
2 |
| 20 |
23051671 | Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats. | 2013 Jan 5 |
2 |
| 21 |
24023648 | Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats. | 2013 |
1 |
| 22 |
24041927 | Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model. | 2013 Oct 15 |
1 |
| 23 |
24148218 | Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner. | 2013 Oct 22 |
2 |
| 24 |
24302978 | Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms. | 2013 |
3 |
| 25 |
22186413 | Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue. | 2012 Feb |
1 |
| 26 |
22245388 | Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures. | 2012 Apr |
1 |
| 27 |
22281473 | The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model. | 2012 Apr 15 |
1 |
| 28 |
22868389 | Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism. | 2012 Sep |
4 |
| 29 |
22915295 | Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats. | 2012 Oct |
2 |